These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33264448)

  • 1. Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer.
    Tsutsui K; Namikawa K; Mori T; Kato K; Jinnai S; Nakama K; Ogata D; Takahashi A; Yamazaki N
    J Dermatol; 2021 Feb; 48(2):e114-e115. PubMed ID: 33264448
    [No Abstract]   [Full Text] [Related]  

  • 2. Panitumumab-induced perforating collagenosis.
    Kluger N; Jokela S; Tolkki L
    Ann Dermatol Venereol; 2024 Jun; 151(2):103271. PubMed ID: 38678770
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired reactive perforating collagenosis.
    Schmults CA
    Dermatol Online J; 2002 Oct; 8(2):8. PubMed ID: 12546763
    [No Abstract]   [Full Text] [Related]  

  • 4. Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.
    Jiang X; Song TT; Hao F
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):548-551. PubMed ID: 34219432
    [No Abstract]   [Full Text] [Related]  

  • 5. Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.
    Lederhandler M; Beasley JM; Brinster NK; Nagler AR
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive perforating collagenosis during erlotinib therapy.
    Suzuki Y; Yamamoto T
    Acta Derm Venereol; 2012 Mar; 92(2):216-7. PubMed ID: 22101862
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactive perforating collagenosis masquerading as rheumatoid arthritis.
    Bhatt AD; Joshi A; Jain J; Gupta O
    Singapore Med J; 2010 Aug; 51(8):676-7. PubMed ID: 20848067
    [No Abstract]   [Full Text] [Related]  

  • 8. A giant variant of acquired reactive perforating collagenosis.
    Kusutani N; Arai S; Imanishi A; Maekawa N; Fukai K
    Int J Dermatol; 2022 Jul; 61(7):e250-e252. PubMed ID: 34302354
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired reactive perforating collagenosis: current status.
    Karpouzis A; Giatromanolaki A; Sivridis E; Kouskoukis C
    J Dermatol; 2010 Jul; 37(7):585-92. PubMed ID: 20629824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.
    Huseynova L; Akdogan N; Gököz Ö; Evans SE
    An Bras Dermatol; 2020; 95(3):336-339. PubMed ID: 32359703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of acquired reactive perforating collagenosis with itraconazole.
    Ye B; Cao Y; Liu Y
    Eur J Med Res; 2021 Jul; 26(1):74. PubMed ID: 34256825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Reactive Perforating Collagenosis Associated with Linear Immunoglobulin A Bullous Disease.
    Tan Q; Liu L; Zhang J; Ni SL
    Acta Derm Venereol; 2020 Sep; 100(16):adv00268. PubMed ID: 32945340
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol.
    Hoque SR; Ameen M; Holden CA
    Br J Dermatol; 2006 Apr; 154(4):759-62. PubMed ID: 16536825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult, acquired reactive perforating collagenosis. Report of a case including ultrastructural findings.
    Beck HI; Brandrup F; Hagdrup HK; Jensen NK; Starklint H
    J Cutan Pathol; 1988 Apr; 15(2):124-8. PubMed ID: 3372790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive perforating collagenosis: dermoscopic aspects and differential diagnosis.
    Adya KA; Inamadar A
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38594202
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactive perforating collagenosis: a rare side effect associated with sorafenib.
    Vega Díez D; Gómez Zubiaur A; Medina Montalvo S
    Rev Esp Enferm Dig; 2020 Dec; 112(12):960-961. PubMed ID: 33226256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive perforating collagenosis.
    Yadav MK; Sangal BC; Bhargav P; Jai PR; Goyal M
    Indian J Pathol Microbiol; 2009; 52(1):106-7. PubMed ID: 19136799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired reactive perforating collagenosis following herpes zoster as isotopic response?].
    Scola N; Gambichler T; Altmeyer P; Stücker M; Kreuter A
    Hautarzt; 2011 Sep; 62(9):683-7. PubMed ID: 21732160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol.
    Iyoda M; Hayashi F; Kuroki A; Shibata T; Kitazawa K; Sugisaki T; Sakai O
    Am J Kidney Dis; 2003 Sep; 42(3):E11-3. PubMed ID: 12955705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.